Comatotropny hormone and insulin-like growth factors in the pathogenesis of fetal growth retardation

Written by Kocherova V.V., Scherbak V.A.

  UDK: 618.29:612.433,65:577.112.3 | Pages: 5–8 | Full text PDF | Open PDF 


Review article on the endocrine regulation of fetal growth retardation. Somatomedins and growth hormone have a similar structure of the peptide, but their influence on fetal growth varies. During pregnancy, the insulin growth factor-2 plays an important role, after the birth-insulin-like growth factor-1. Hormonal profile of the mother, her somatic disorders, the impact of external factors, production of hormones by the placenta, and gene polymorphism insulin-like growth factors influence the development of the fetus and newborn.

Links to authors:

V.V. Kocherova, V.A. Scherbak
Chita State Medical Academy (39a Gorkogo St. Chita 672090 Russian Federation)

1. Andreeva V.O. The role of growth hormone and somatomedin in the pathogenesis of certain reproductive disorders at a syndrome of anorexia nervosa // Kazan Medical Journal. 2008. Vol. 89, No. 2. P. 143–145.
2. Dubova E.A., Pavlova K.A., Lyapin V.M [et al.]. Expression of insulin-like growth factors in the placenta in pre-eclampsia // Bulletin of Experimental Biology and Medicine. 2014. Vol. 157, No. 1. P. 116–121.
3. Joseph New. Gastroenterology and Nutrition // Problems and contradictions in neonatology / edited by R.A. Polin. М.: Logosfera, 2014. P. 221–337.
4. Islaimova K.F., Petrenko Yu.V., Ivanov D.O. [et al.]. Effect of insulin- like growth factor-1 on fetal and postnatal growth in children born with intrauterine growth retardation // Bulletin of Contemporary Clinical Medicine. 2013. Vol. 6, No. 6. P. 36–39.
5. Kolychev A.P. Insulin-like growth factor II (IGF-2). Place among the regulators of insulin peptides // Journal of Evolutionary Biochemistry and Physiology. 2000. Vol. 36, No. 2. P. 69–82.
6. Pronin V.S., Koloda D.E., Chaplygina E.V. Insulin-like growth factors in clinical practice: the biological role and prospects // The Clinician. 2008. No. 1. P. 18–26.
7. Shulga A.S., Butenko E.V., Aleksandrova A.A. [et al.]. Assessment of ghrelin levels change, growth hormone, insulin-like growth factor-1, insulin, leptin, thyroid hormones in maternal and umbilical cord blood at a normal pregnancy with fetal macrosomia and normosomiey // Russian Clinical Laboratory Diagnostics. 2013. No. 2. P. 16–18.
8. Abuzzahab M.J., Schneider A., Goddard A. [et al.]. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation // N. Engl. J. Med. 2003. Vol. 349, No. 23. P. 2211–2222.
9. Baker Méio M.D., Lopes Moreira M.E., Sichieri R. [et al.]. Reduction of IGF-binding protein-3 as a potential marker of intrauterine growth restriction // J. Perinat. Med. 2009. Vol. 37, No. 6. P. 689–693.
10. Bauer M.K., Harding J.E., Bassett N.S. [et al.]. Fetal growth and placental function // Mol. Cell. Endocrinol. 1998. Vol. 140, No. 1–2. P. 115–120.
11. Bowman C.J., Streck R.D., Chapin R.E. Maternal-placental insulin- like growth factor (IGF) signaling and its importance to normal embryo-fetal development // Birth. Defects. Res. B. Dev. Reprod. Toxicol. 2010. Vol. 89, No. 4. P. 339–349.
12. Herington A.C., Kuffer A.D. Insulin-like growth factor characteristics of an acidic non-suppressible insulin-like activity // Biochem. J. 1984. Vol. 223, No. 1. P 89–96.
13. D’Ercole J.A., Ye P. Expanding the mind: insulin-like growth factor I and brain development // Endocrinology. 2008. Vol. 149, No. 12. P. 5958–5962.
14. Guler H.P., Schmid C., Zapf J. [et al.]. Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects // Proc. Natl. Acad. Sci. USA. 1989. Vol. 86, No. 8. P. 2868–2872.
15. Hiden U., Glitzner E., Hartmann M. [et al.]. Insulin and the IGF system in the human placenta of normal and diabetic pregnancies // J. Anat. 2009. Vol. 215, No. 1. P. 60–68.
16. Jansson N., Nilsfelt A., Gellerstedt M. [et al.]. Maternal hormones linking maternal body mass index and dietary intake to birth weight // Am. J. Clin. Nutr. 2008. Vol. 87, No. 6. P. 1743–1749.
17. Kedzia A., Tarka A., Petriczko E. [et al.]. Placental growth hormone (PGH), pituitary growth hormone (GH1), insulin-like growth factor (IGF-I) and ghrelin in pregnant women›s blood serum // Ginekol. Pol. 2013. Vol. 84, No. 7. P. 620–623.
18. King E.R., Wong K.K. Insulin-like growth factor: current concepts and new developments in cancer therapy // Recent Pat. Anticancer Drug Discov. 2012. Vol. 7, No. 1. P. 14–30.
19. Koutsaki M., Sifakis S., Zaravinos A. [et al.]. Decreased placental expression of hPGH, IGF-I and IGFBP-1 in pregnancies complicated by fetal growth restriction // Growth. Horm. IGF. Res. 2011. Vol. 21, No. 1. P. 31–36.
20. Kuemmerle J. F. Insulin-like growth factors in the gastrointestinal tract and liver // Endocrinol. Metab. Clin. North. Am. 2012. Vol. 41, No. 2. P. 409–423.
21. Lagiou P., Hsieh C.C., Samoli E. [et al.]. Associations of placental weight with maternal and cord blood hormones // Ann. Epidemiol. 2013. Vol. 23, No. 11. P. 669–673.
22. Lee P.D., Conover C.A., Powell D.R. Regulation and function of insulin-like growth factor-binding protein-1 // Proc. Soc. Exp. Biol. Med. 1993. Vol. 204, No. 1. P. 4–29.
23. Mahajan S.D., Singh S., Shah P. [et al.]. Effect of maternal malnutrition and anemia on the endocrine regulation of fetal growth // Endocr. Res. 2004. Vol. 30, No. 2. P. 189–203.
24. McMorris F.A., Smith T.M., DeSalvo S. [et al.]. Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development // Proc. Natl. Acad. Sci. USA. 1986. Vol. 83, No. 3. P. 822–826.
25. Nelson S.M., Freeman D.J., Sattar N. [et al.]. Role of adiponectin in matching of fetal and placental weight in mothers with type 1 diabetes // Diabetes Care. 2008. Vol. 31, No. 6. P. 1123–1125.
26. Ong K., Kratzsch J., Kiess W. [et al.]. Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGFbinding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/ mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team Avon Longitudinal Study of Pregnancy and Childhood // J. Clin. Endocrinol. Metab. 2000. Vol. 85, No. 11. P. 4266–4269.
27. Ong K.K., Elmlinger M., Jones R. [et al.]. Growth hormone binding protein levels in children are associated with birth weight, postnatal weight gain, and insulin secretion // Metabolism. 2007. Vol. 56, No. 10. P. 1412–1417.
28. de Pablo F.L., Scott L.A., Roth J. Insulin and insulin-like growth factor I in early development: peptides, receptors and biological events // Endocr. Rev. 1990. Vol. 11, No. 4. P. 558–577.
29. Pedersen N.G., Juul A., Christiansen M. [et al.]. Maternal serum placental growth hormone, but not human placental lactogen or insulin growth factor-1, is positively associated with fetal growth in the first half of pregnancy // Ultrasound. Obstet. Gynecol. 2010. Vol. 36, No. 5. P. 534–541.
30. Ranke M.B. Sensitivity to IGF-I in short children born small for gestational age // J. Endocrinol. Invest. 2006. Vol. 29 (Suppl. 1). P. 21–26.
31. Sara V.R., Carlsson-Skwirut C., Andersson C. [et al.]. Characterization of somatomedins from human fetal brain: identification of a variant form of insulin-like growth factor I // Proc. Natl. Acad. Sci. USA. 1986. Vol. 83, No. 13. P. 4904–4907.
32. Setia S, Sridhar MG. Changes in GH/IGF-1 axis in intrauterine growth retardation: consequences of fetal programming? // Horm. Metab. Res. 2009. Vol. 41, No. 11. P. 791–798.
33. Sferruzzi-Perri A.N., Owens J.A., Pringle K.G. [et al.]. The neglected role of insulin-like growth factors in the maternal circulation regulating fetal growth // J. Physiol. 2011. Vol. 589. P. 7–20.
34. Tonella P. Mullis P.E. Regulation of fetal growth: consequences and impact of being born small // Best Pract. Res. Clin. Endocrinol. Metab. 2008. Vol. 22, No. 1. P. 173–190.
35. Unterman T.G. Insulin-like growth factor binding protein-1: identification, purification, and regulation in fetal and adult life // Adv. Exp. Med. Biol. 1993. Vol. 343. P. 215–226
36. Whitehead C.L., Walker S.P., Mendis S. [et al.]. Quantifying mRNA coding growth genes in the maternal circulation to detect fetal growth restriction // Am. J. Obstet. Gynecol. 2013. Vol. 209, No. 2. P. 133. e1–9.
37. Wiznitzer A., Reece E.A., Furman B. [et al.]. Fetal serum levels of insulin, growth hormone and insulin-like growth factor-I in concordant and discordant twin gestations // J. Matern. Fetal. Med. 2001. Vol. 10, No. 4. P. 236–240.
38. Zhou J., Shi Y., Dong M. Influence of growth hormone-insulinlike growth factor I axis on normal pregnancy // Chin. Med. J. (Engl). 2001. Vol. 114, No. 9. P. 988–990.


Founded in 1997  |  Editions in a year: 4, Articles in one issue: 30 |  ISSN of print version: 1609-1175  |  Ind.: 18410 (Agency "Rospechat’")  |  Edition: 1000 c.